Previous studies have suggested that SHPT is associated with hyperphosphatemia, CaSR, vitamin D receptor, fibroblast growth factor-23, down-regulation of PTH receptor expression, reduced target organ responsiveness to PTH, PTH metabolic disorders, and regulation of miRNAs [4, 5]. Here, PTH is linked to metabolic disease.